Fetal programming associated with intrauterine growth restriction (IUGR) predisposes offspring to lifelong metabolic dysfunction [1,2], including impaired skeletal muscle glucose metabolism and poor insulin secretion [3,4]. The gene discussed is INS; the disease is fetal growth restriction.